Review
doi: 10.1093/eurheartj/ehm209.
Epub 2007 Jul 5.
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval
Affiliations
- PMID: 17615083
- DOI: 10.1093/eurheartj/ehm209
Item in Clipboard
Review
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval
Eur Heart J.
2007 Aug.
Free article
Abstract
Recently, several drugs for non-cardiovascular diseases have ceased marketing because of cardiovascular risk, highlighting the importance of evaluating the cardiovascular safety of new drugs even if not intended for cardiovascular diseases. Assessing and ensuring acceptable cardiovascular safety of non-cardiovascular drugs is difficult; nonetheless, governmental regulatory agencies are likely to change the requirements for drug safety information. This article explores our recommendations for rethinking current regulatory policies, emphasizing the need for mandatory post-marketing surveillance registries and highlighting the exposures necessary to subserve the need for greater assessment of safety issues.
Similar articles
-
Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.Consum Rep. 2006 Jan;71(1):34-9. Consum Rep. 2006. PMID: 16491527 No abstract available.
-
Opening Pandora's pillbox: using modern information tools to improve drug safety.Health Aff (Millwood). 2005 Jul-Aug;24(4):938-48. doi: 10.1377/hlthaff.24.4.938. Health Aff (Millwood). 2005. PMID: 16012136
-
Safety in numbers--monitoring risk in approved drugs.N Engl J Med. 2005 Mar 24;352(12):1173-6. doi: 10.1056/NEJMp058029. N Engl J Med. 2005. PMID: 15788493 No abstract available.
-
Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91. doi: 10.1377/hlthaff.26.2.483. Health Aff (Millwood). 2007. PMID: 17339677 Review.
-
[The safety of drugs].Rev Clin Esp. 1990 Sep;187(4):184-90. Rev Clin Esp. 1990. PMID: 2091076 Review. Spanish.
Cited by
-
D-glucosamine promotes transfection efficiency during electroporation.Biomed Res Int. 2014;2014:485867. doi: 10.1155/2014/485867. Epub 2014 Feb 11. Biomed Res Int. 2014. PMID: 24678506 Free PMC article.
-
Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings.J Toxicol Pathol. 2010 Dec;23(4):189-211. doi: 10.1293/tox.23.189. Epub 2010 Dec 16. J Toxicol Pathol. 2010. PMID: 22272031 Free PMC article.
-
Reaction to the recent publication by rosemary basson entitled 'testosterone therapy for reduced libido in women'.Ther Adv Endocrinol Metab. 2011 Apr;2(2):95-6. doi: 10.1177/2042018811404034. Ther Adv Endocrinol Metab. 2011. PMID: 23148174 Free PMC article. No abstract available.
-
Suppressive effects of D-glucosamine on the 5-HT sensitive nociceptive units in the rat tooth pulpal nerve.Biomed Res Int. 2014;2014:187989. doi: 10.1155/2014/187989. Epub 2014 Apr 13. Biomed Res Int. 2014. PMID: 24818130 Free PMC article.
-
D-glucosamine conjugation accelerates the labeling efficiency of quantum dots in osteoblastic cells.Biomed Res Int. 2014;2014:821607. doi: 10.1155/2014/821607. Epub 2014 Mar 24. Biomed Res Int. 2014. PMID: 24818156 Free PMC article.
